Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial

dc.contributor.authorMaría Elvira Balcells
dc.contributor.authorLuis Rojas
dc.contributor.authorNicole Le Corre
dc.contributor.authorConstanza Martínez-Valdebenito
dc.contributor.authorMaría Elena Ceballos
dc.contributor.authorMarcela Ferrés
dc.contributor.authorMayling Chang
dc.contributor.authorCecilia Vizcaya
dc.contributor.authorSebastián Mondaca
dc.contributor.authorÁlvaro Huete
dc.contributor.authorRicardo Castro
dc.contributor.authorMauricio Sarmiento
dc.contributor.authorLuis Villarroel
dc.contributor.authorAlejandra Pizarro
dc.contributor.authorPatricio Ross
dc.contributor.authorJaime Santander
dc.contributor.authorBarbara Lara
dc.contributor.authorMarcela Ferrada
dc.contributor.authorSergio Vargas-Salas
dc.contributor.authorCarolina Beltrán-Pavez
dc.contributor.authorRicardo Soto-Rifo
dc.contributor.authorFernando Valiente-Echeverría
dc.contributor.authorChristian Caglevic
dc.contributor.authorMauricio Mahave
dc.contributor.authorCarolina Selman
dc.contributor.authorRaimundo Gazitúa
dc.contributor.authorJosé Luis Briones
dc.contributor.authorFranz Villarroel-Espindola
dc.contributor.authorCarlos Balmaceda
dc.contributor.authorManuel A. Espinoza
dc.contributor.authorJaime Pereira
dc.contributor.authorBruno Nervi
dc.date.accessioned2023-05-19T20:46:35Z
dc.date.available2023-05-19T20:46:35Z
dc.date.issued2020
dc.fuente.origenORCID-mayo23
dc.identifier.doi10.1101/2020.09.17.20196212
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/69819
dc.titleEarly Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Triales_ES
dc.typeotro
Files